🇺🇸 FDA
Patent

US 6946133

Prostate specific antigen oligo-epitope peptide

expired A61KA61K2035/124A61K2039/5154

Quick answer

US patent 6946133 (Prostate specific antigen oligo-epitope peptide) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Sep 15 2025 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Sep 20 2005 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 15 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K2035/124, A61K2039/5154, A61K2039/5156, A61K2039/5158